by MM360 Staff | May 29, 2025 | Uncategorized
Source: CureToday articles Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining treatment with PARP inhibitors. Read More
by MM360 Staff | May 28, 2025 | Uncategorized
Source: CureToday articles Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer. Read More
by MM360 Staff | May 28, 2025 | Uncategorized
Source: CureToday articles Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, including GIST and some leukemias. Read More
by MM360 Staff | May 28, 2025 | Uncategorized
Source: CureToday articles After running the Boston Marathon at 67, I faced new limits from aging and chronic lymphocytic leukemia — but I’ve found ways to stay strong and resilient. Read More
by MM360 Staff | May 28, 2025 | Uncategorized
Source: CureToday articles ATR-04 therapy is being investigated in the phase 1/2 ATR04-484 clinical trial for the treatment of EGFR inhibitor-associated rashes in lung cancer. Read More
by MM360 Staff | May 28, 2025 | Uncategorized
Source: CureToday articles Neoadjuvant efti and Keytruda plus radiotherapy met the EFTISARC-NEO trial’s primary end point by improving tumor fibrosis in soft tissue sarcoma. Read More
